PCA Investment Advisory Services’s AbbVie ABBV Stock Holding History

PCA Investment Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-285	Closed	-$38.5K	–	113
2023 Q2	$38.5K	Buy	+285	New	+$41.8K	0.02%	288

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCA Investment Advisory Services's ABBV Position: Q3 2023 in Review

PCA Investment Advisory Services sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 285 shares — an estimated $38.5K sold.

PCA Investment Advisory Services first reported a position in ABBV in Q2 2023 and held it in 1 quarter. The position peaked at $38.5K in Q2 2023. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

PCA Investment Advisory Services reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
PCA Investment Advisory Services sold 285 AbbVie shares in Q3 2023, an estimated $38.5K.
PCA Investment Advisory Services first reported a position in AbbVie in Q2 2023 and held it in 1 quarter.
PCA Investment Advisory Services's AbbVie position peaked at $38.5K in Q2 2023.
3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on PCA Investment Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.